Skip to content
value.today

TMRW Life Sciences, Inc.

🇺🇸 New York, New York, USAHealth CareFounded 2018
Total raised
$185 M
4 rounds on record
Latest round
$28 M
Jun 2024
First round on record
Dec 2019
Today
Private
No later event on record

Funding rounds

4 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of TMRW Life Sciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2026$38 MIssued in a merger or acquisition$10 to $50 million

TMRW Life Sciences, Inc.: Private sale, Mar 2026

Investors in this round

59 investors had bought by the notice of Apr 24, 2026: 59 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$38 M of $38 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Louis Villalba · Executive Officer, Director
  • Andrew Schwab · Director
  • Emily Drabant Conley · Director
  • Greg Eisner · Director
  • Jeffrey Port · Director
  • Vinay Shah · Director
  • William Schoolcraft · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Louis Villalba, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 24, 2026. Read the notice at the SEC.

equitySEC
Jun 2024$28 MNo. 4$10 to $50 million

TMRW Life Sciences, Inc.: Raise no. 4, Jun 2024

Investors in this round

69 investors had bought by the notice of Jul 12, 2024: 69 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $30 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alan Drabant Murray · Director
  • Andrew Drabant Schwab · Director
  • Emily Drabant Conley · Director
  • Jeffrey Drabant Port · Director
  • Joshua Abram · Director
  • Louis Drabant Villaba · Director
  • Roberta Drabant Myers · Director
  • Vinay Drabant Shah · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Louis Villalba, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 12, 2024. Read the notice at the SEC.

equitySEC
Jun 2021$100 MNo. 3$50 to $250 million

TMRW Life Sciences, Inc.: Raise no. 3, Jun 2021

Investors in this round

59 investors had bought by the notice of May 13, 2022: 59 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$100 M of $102 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Melanie Goldey · Executive Officer
  • Tara Comonte · Executive Officer, Director
  • Alan Murray · Director
  • Andrew Schwab · Director
  • Emily Conley · Director
  • Jeffrey Port · Director
  • Joshua Abram · Director
  • Roberta Myers · Director
  • Vinay Shah · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes amounts paid in both cash and pursuant to conversion of indebtedness.”

Signed by Steve Gordon, Chief Legal Officer. Source: SEC Form D and 1 amendment, newest notice filed May 13, 2022. Read the notice at the SEC.

equitySEC
Feb 2021$20 MNo. 2$10 to $50 million

TMRW Life Sciences, Inc.: Raise no. 2, Feb 2021

Investors in this round

35 investors had bought by the notice of Feb 12, 2021: 35 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alan Murray · Director
  • Andrew Schwab · Director
  • Emily Conley · Director
  • Jeffrey Port · Director
  • Joshua Abram · Director
  • Roberta Myers · Director
  • Tara Comonte · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Gordon, Chief Legal Officer. Source: SEC Form D, newest notice filed Feb 12, 2021. Read the notice at the SEC.

debt, optionsSEC
Dec 2019$37 MNo. 1$10 to $50 million

TMRW Life Sciences, Inc.: Raise no. 1, Dec 2019

Investors in this round

34 investors had bought by the notice of May 19, 2020: 34 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $37 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alan Murray · Director
  • Andrew Drabant Schwab · Director
  • Emily Drabant Conley · Director
  • Jeffrey Port · Director
  • Joshua Abram · Director
  • Roberta Drabant Myers · Director
  • Tara Comonte · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Gordon, Chief Legal Officer. Source: SEC Form D and 1 amendment, newest notice filed May 19, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • TMRW Life Sciences, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2026).

    SEC Form D · Apr 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2026

That is all the official record says: TMRW Life Sciences, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of TMRW Life Sciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 69 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by TMRW Life Sciences, Inc.
NameRoleNamed in
Louis VillalbaExecutive officerApr 2026
Melanie GoldeyExecutive officerMay 2022
Tara ComonteExecutive officerMay 2022
Andrew SchwabDirectorApr 2026
Emily Drabant ConleyDirectorApr 2026
Greg EisnerDirectorApr 2026
Jeffrey PortDirectorApr 2026
Louis VillalbaDirectorApr 2026
Vinay ShahDirectorApr 2026
William SchoolcraftDirectorApr 2026
Alan Drabant MurrayDirectorJul 2024
Andrew Drabant SchwabDirectorJul 2024
Jeffrey Drabant PortDirectorJul 2024
Joshua AbramDirectorJul 2024
Louis Drabant VillabaDirectorJul 2024
Roberta Drabant MyersDirectorJul 2024
Vinay Drabant ShahDirectorJul 2024
Alan MurrayDirectorMay 2022
Emily ConleyDirectorMay 2022
Roberta MyersDirectorMay 2022
Tara ComonteDirectorMay 2022